Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans.
Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans.
复制标题
健康人体中 4-甲基吡唑和乙醇之间的动力学相互作用。
DOI:
10.1111/j.1530-0277.1996.tb05255.x
复制
发表时间:
1996
期刊:
影响因子:
--
通讯作者:
McMartin,KE
中科院分区:
文献类型:
--
作者:
Jacobsen,D;Sebastian,CS;Dies,DF;Breau,RL;Spann,EG;Barron,SK;McMartin,KE
4‐Methylpyrazole (4‐MP), a potent inhibitor of alcohol dehydrogenase activity, is a candidate to replace ethanol as the antidote for methanol and ethylene glycol intoxications, because It has a longer duration of action and apparently fewer adverse effects. To study a probable mutual inhibitory effect between ethanol and 4‐MP on their elimination, two studies were performed in healthy human volunteers using double‐blind crossover designs. In study A, 4‐MP in the presumed therapeutic dose range of 10 to 20 mg/kg caused a 40% reduction in the rate of elimination of ethanol in 12 subjects given 0.5 to 0.7 g/kg of ethanol. These data suggest that such doses of CMP inhibit alcohol dehydrogenase activity in humans in vivo and would be effective at blocking methanol or ethylene glycol metabolism. In study B, ethanol (0.6 g/kg followed by 0.2 g/kg twice) significantly decreased the rate of elimination of 4‐MP (5 mg/kg, given intravenously to four subjects). These moderate doses of ethanol also inhibited the rate of urinary excretion of 4‐carboxypyrazole, the primary metabolite of 4‐MP in humans. Data suggest that ethanol inhibits 4‐MP metabolism, thereby increasing the duration of therapeutic blood levels of CMP in the body. This mutual interaction may have clinical implications, because most self‐poisoned patients have also ingested ethanol. Theoretically, methanol and ethylene glycol might also show such interactions with 4‐MP.